HOME >> BIOLOGY >> NEWS
$6.5M nanomedicine center includes Yale engineer

New Haven, Conn. --A Yale scientist is among the recipients of a special $6.5 million center grant from the National Eye Institute of the National Institutes of Health, intended to rapidly launch revolutionary ideas in the use of nanomedicine and serve as the centerpiece of its Nanomedicine Roadmap Initiative.

David A. LaVan, an assistant professor of mechanical engineering and member of Yale's Interdisciplinary Neuroscience Program, will participate in the National Center for Design of Biomimetic Nanoconductors, one of the four centers funded. The center will be led by Professor Eric G. Jakobsson at the University of Illinois Urbana-Champaign.

The five-year grant will support a multidisciplinary and multi-institutional project to design, model, synthesize and fabricate nanomedical devices based on natural and synthetic ion transporters, proteins that control ion motion across the membrane of every living cell. Nanomedicine operates at the biological molecule scale of 100 nanometers or less to cure disease or repair damaged tissues. A nanometer is one-billionth of a meter.

The first target for the center will be to design a class of devices for generating electric power --biobatteries -- for a wide array of implantable devices, including an artificial retina. LaVan, who was recently awarded a grant from the Keck Foundation to develop novel materials to convert sunlight into electricity, will oversee design of the biobattery for the Center.

"This focus is intended to leverage our significant understanding of ion transport at the molecular level," said LaVan, who chaired a group at the 2004 National Academies Keck Futures Conference, Designing Nanostructures, where aspects of this project were formulated. "We are set to develop revolutionary new devices to treat disease and to develop implantable devices that mimic natural functions."

The team expects to construct several categories of devices including sensors, power source
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
14-Oct-2005


Page: 1 2

Related biology news :

1. Barcelona University, ESF to host nanomedicine conferences
2. $16 million grant advances nanomedicine at Washington University
3. Multicenter study nets new lung tumor-suppressor gene
4. Brains hearing center may reorganize after implant of cochlear device
5. UC Davis is partner in new $125 million federal bioenergy research center
6. ORNL-led team wins DOE bioenergy center
7. Research center unites biomedical competitors to fund medical technology development
8. Fibers are center stage at international conference
9. 3M Manchester research center to develop vital new science
10. UC Davis wins new national center for avian flu research
11. University and health science center in San Antonio collaborate to find chlamydia vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: nanomedicine center includes Yale engineer

(Date:4/17/2014)... hundred births, Down syndrome - or trisomy 21 - ... It results from a chromosomal abnormality where cells of ... (1% of the human genome). A study conducted by ... Genetic Medicine and Development at the University of Geneva ... shed light on how the extra chromosome 21 upsets ...
(Date:4/17/2014)... Rajendra Singh Thursday as a "Champion of Change" ... deployment in the residential, commercial and industrial sectors. ... Electrical and Computer Engineering and director of Clemson,s ... hero leading the charge across the country to ... and driving policy changes at the local level ...
(Date:4/17/2014)... channels are implicated in many serious conditions such as ... potential target for drug therapies. Unfortunately, there is still ... Cambridge research provides fresh and unexpected insight into the ... components - β-subunit molecules - which are responsible for ... published in the most recent edition of the ...
Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2
(Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
(Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
Cached News: